Prevention of hepatitis C virus (HCV) and HIV-1 co-infections through induction of potent T cell responses using prime-boost viral vector vaccine regimens

Project Information

PEACHI

Grant agreement ID: 305632

Project closed

Start date 1 February 2013

End date 31 October 2017

Funded under

• Specific Programme "Cooperation": Health

Total cost

€ 6 062 182,86

EU contribution

€ 4 388 813,00

Coordinated by

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

• Combined vaccine strategy targets both hepatitis C virus and HIV
  EN